Connect With the Liquid Biopsy & Precision Medicine Community
With new players entering the liquid biopsy landscape every day, precision oncology has never been more competitive. Partnerships are no longer secured on performance alone, regulatory alignment, cost efficiency, analytical sensitivity, turnaround time and scalability all influence decision-making.
Biopharma developers are actively evaluating who truly leads across these dimensions and which emerging innovators are redefining the field.
At the 5th Liquid Biopsy for Precision Oncology Summit East Coast unite with senior pharma leaders to discuss the most pressing liquid biopsy challenges facing their programs, and to position your technology as the answer.
We tailor every partnership to align with your strategic objectives, but potential options include:
- Program Partner: Deliver a 30-minute presentation to the full audience, placing your platform at the center of discussions on how liquid biopsy is transforming drug development.
- Panel Partner: Moderate a high-profile panel discussion, demonstrate thought-leadership on critical industry topics and reinforce your reputation as a trusted expert in the space.
- Meeting Partner: Gain visibility into who is attending, secure curated one-to-one meetings and build meaningful partnerships with precision oncology decision-makers.
Whether you differentiate through regulatory readiness, ultra-sensitive detection, operational excellence or integrated end-to-end solutions, elevate your presence in front of 100+ precision medicine decision-makers and demonstrate why you should be their next strategic partner.
What You Will Gain in Partnering
Meet New Biopharma Decision-Makers
Expand your network by connecting face-to-face with senior precision medicine leaders actively seeking solutions to advance their liquid biopsy strategies across patient selection, MRD and companion diagnostics.
Position Yourself at the Centre of Precision Oncology Strategy
Place your brand in front of senior translational, clinical and precision medicine leaders through prominent visibility across our website, brochure and onsite materials.
Demonstrate Your Liquid Biopsy Capabilities
Present your data within a focused session, moderate a strategic panel discussion or showcase your platform to highlight how your technology strengthens trial design, accelerates decisions and supports regulatory progress.
Gain Actionable Market Intelligence
Hear directly from pharma leaders shaping ctDNA and MRD strategy, understand evolving regulatory expectations and benchmark your positioning against competitors in this rapidly advancing field.
Key Interest Areas
Our highly-targeted audience of liquid biopsy experts are looking for service and solution providers with capabilities in the following areas:
Liquid Biopsy Assay Developers
Position your assay at the centre of strategic pharma discussions around MRD, molecular response and companion diagnostics. Engage directly with translational and clinical leaders evaluating platforms for current and future oncology programs.
Biospecimen & Data Providers
Connect with drug developers seeking high-quality samples and data infrastructure to enable robust assay validation, longitudinal monitoring and regulator-ready evidence generation.
Technology, Instrument & Kit Providers
Spotlight the platforms powering next-generation liquid biopsy workflows and demonstrate how your solutions enhance sensitivity, scalability, turnaround time and operational efficiency.
Contract Research Organizations
Meet biopharma teams outsourcing biomarker strategy, assay validation and trial execution, and position your expertise as critical to delivering reliable, decision-grade molecular insights.
AI & Bioinformatic Liquid Biopsy Analysis Providers
Meet with sponsors looking to transform complex multi-omic data into actionable clinical decisions, and demonstrate how your analytics can accelerate trial readouts, patient stratification and regulatory confidence.
Hear What Our Past Sponsors Have to Say
This is a very focused meeting with good content and strong engagement from industry attendees
Vice President, SAGA Diagnostics, Past Sponsor
Hanson Wade’s level of professionalism and attention to the delegates, speakers and partners is top notch
Director, Business Development, Personalis, 2026 Sponsor
Audience Composition
Company Type
*Statistics taken from the 4th Liquid Biopsy for Precision Oncology Summit East Coast
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth, panel and speaking slots to more bespoke deliverables such as badges, exclusive dinners and tours to support you in elevating your brand.
Get in Touch
Take advantage of our bespoke partnership opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Sam Sarwar
Senior Commercial Director
Maintain Your Competitive Edge
Position your liquid biopsy solution at the centre of high-level pharma discussions shaping precision oncology strategy.
Network With Decision-Makers
Connect with senior translational and clinical leaders during structured networking and dedicated partnering sessions.
Showcase Your Capabilities
Leverage bespoke sponsorship opportunities across branding, speaking and exhibition to align your presence with your strategic goals.